Trial confidentiality set to disappear as EU MPs pass regulation
This article was originally published in Scrip
Executive Summary
New European clinical trial legislation pressuring companies to disclose more clinical data is a step closer to coming into force after approval from the European Parliament on 29 May. But its still not clear what information will remain commercially confidential, and uncertainty makes industry nervous.
You may also be interested in...
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
New HTA Evidence Guidelines In EU Could Spell Trouble For Advanced Therapy Companies
New guidelines that cast doubt over use of single-arm and non-randomized studies are “discouraging” for rare disease patients and the advanced therapy sector, says ARM, the Alliance for Regenerative Medicines.
Germany Courts Clinical Trials With Regulator Reshuffle & New Federal Ethics Committee
Plans to rejig two regulators’ roles and streamline the ethics committee system have drawn some criticism.